Attention, legal professionals. A recent final rule from the Drug Enforcement Administration (DEA), put into action July 24, 2023, has significant implications for corporate entities and individuals registered to manufacture, distribute, or dispense controlled substances. As reported by Foley & Lardner LLP on JD Supra, the key change is in the submission requirements for the DEA’s “Form 106”, which provides information about the theft or significant losses of controlled substances.
Previously, registrants were allowed to provide reports of theft or substantial losses in written form. However, under the new regulations, DEA will now require that these reports be submitted electronically. Moreover, a deadline of 45 calendar days from the discovery of the theft or loss is imposed on all submissions. It means the form must be sent within a month and a half of noticing a significant loss or robbery of controlled substances. This change potentially necessitates adjustments to corporate compliance mechanisms.
Under the previous rule, there was some flexibility in the time frame for reporting, providing companies with the leeway to conduct internal investigations before making a formal report. Now, the establishment of a firm deadline compels companies to act more promptly upon identifying a theft or loss.
This administrative shift may impact how companies handle internal audits, losses, thefts or potential regulation violations involving controlled substances. To ensure compliance, companies might need to streamline their internal investigation processes, boost their electronic record-keeping systems, or revamp their reporting mechanisms.
In conclusion, the new DEA ruling could potentially exert substantial influence on corporate registrants in the controlled substances field. It is advisable for legal professionals in this sector to familiarize themselves with the details of this important regulatory change and consider its implications for their clients’ or their organizations’ compliance systems.